Mesenchymal stromal stem cells (MSCs) possess a remarkable potential for numerous
clinical applications due to their unique properties including self-renewal …

Advances in stem cell technology offer new possibilities for patients with untreated diseases
and disorders. Stem cell-based therapy, which includes multipotent mesenchymal stem cells …

The associations between inflammation and tissue regeneration are highly conserved
during the evolution of multicellular organisms [1]. Appropriate activation of immune cells is …

Recently, therapies utilizing extracellular vesicles (EVs) derived from mesenchymal
stromal/stem cells (MSCs) have begun to show promise in clinical trials. However, EV …

In the recent past, the formulation and development of nanocarriers has been elaborated
into the broader fields and opened various avenues in their preclinical and clinical …

There is considerable interest in the potential for cell-based therapies, particularly
mesenchymal stromal cells (MSCs) and their products, as a therapy for acute respiratory …

Mesenchymal stromal/stem cells (MSC) have emerged as a promising therapeutic avenue
for treating autoimmune diseases, eliciting considerable interest and discussion regarding …

Mesenchymal stem/stromal cells (MSCs) represent a heterogeneous cell population
distributed throughout various tissues, demonstrating remarkable adaptability to …

Mesenchymal stem cells (MSCs) are a promising cell source for stem cell therapy of
intractable diseases in veterinary medicine, but donor-dependent cellular heterogeneity is …

Mesenchymal stromal cells (MSC) have immunomodulatory and hematopoiesis-supporting
properties that could potentially benefit hematopoietic stem cell (HSC) engraftment and …